Methylprednisolone Recruiting Phase 3 Trials for Inflammatory Responses / Congenital Heart Disease in Children Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03229538STeroids to REduce Systemic Inflammation After Infant Heart Surgery